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Abstract
BACKGROUND: Recently, outbreak of novel coronavirus (CoV) (severe acute respiratory syndrome-CoV-2 [SARS-
CoV-2]) has been emerged as a serious public health concern. On February 11, 2020, the WHO announced an 
official name for this disease, CoV disease-(COVID)-19. The virus can cause systemic complications such as lung 
involvement, skin, and oral complications.
AIM: The aim of this study was to review of the oral manifestations of COVID-19.
METHODS: In this narrative review study, we searched all articles between 2010 and 2020 in PubMed, Scopus, 
Science Direct related to COVID-19, and its oral manifestations, using the following terms: “Coronavirus,” “COVID-
19,” and “SARS-CoV-2” in combination with “Stomatognathic diseases,” “Oral manifestation,” and “Mouth diseases.”
RESULTS: The most common oral manifestations in people with COVID-19 that we get after searching are: salivary 
gland disease, xerostomia, taste and smell alterations, and oral mucosal lesions.
CONCLUSIONS: Since almost all of the oral findings appear at the asymptomatic phase of disease, identification of 
these symptoms can help to timely diagnosis of the main disease.
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Introduction
The novel coronavirus (CoV) disease 2019 
(COVID) (severe acute respiratory syndrome-CoV-2 
[SARS-CoV-2] or COVID-19) presents as a serious public 
health concern and urgent threat to global health [1].
In December 2019, COVID-19 was detected in 
Wuhan, China. It has a very high transmission capacity 
and is known as SARS-CoV-2 [2].
COVID-19 is highly contagious and it has the 
ability to get transmitted even during asymptomatic 
phase. The infectivity of COVID-19 is greater than that 
of influenza; it is necessary to identify infected people as 
soon as possible, even during the asymptomatic period [3].
The current CoV outbreak is the third epidemic 
viral infection in the 21st century [3]. The lungs are the 
primary site of infection for COVID-19, with patients 
presenting symptoms ranging from mild flu-like 
symptoms to fulminant pneumonia and potentially lethal 
respiratory distress [1].
All age groups are susceptible to the virus and 
some people are more susceptible to the virus such as 
older people (≥ aged 65), patients with immunodeficiency 
or liver and kidney failure, healthcare staff caring for 
COVID-19 patients, and other individuals who closely 
are in contact with these patients in clinical settings [3].
Although the complete clinical representation 
regarding COVID-19 is not fully understood, here are 
some common clinical manifestations. This virus can 
cause disease ranging from mild to severe, the clinical 
characteristics of mild COVID-19 include symptoms 
common to other viral infections (i.e., fever, cough, 
dyspnea, myalgia, fatigue, and diarrhea) [3], [4].
In severe cases, COVID-19 may present as 
acute respiratory distress syndrome, with or without 
both distributive and cardiogenic shock [4].
The oral manifestations of COVID-19 are 
varied and there is insufficient evidence to establish 
an efficient and safe pharmacological agent against 
COVID-19 yet, and the potential ones are related to 
several adverse reactions, including oral lesions [1].
The mouth is one of the sites that can be 
infected by the virus and show manifestations of 
the disease. Therefore, dentists can be one of the 
first people to diagnose the disease based on oral 
manifestations, even in the asymptomatic stages, and 
prevent the spread of the disease. Our purpose in this 
study is to identify and summarize oral manifestations 
related to COVID-19.
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Search Strategy
This article is a narrative review study and 
according to its nature as “narrative,” we chose the most 
relevant contributions to oral manifestations of COVID-19.
The search was conducted using six MeSH 
keywords including, “Coronavirus,” “COVID-19,” “SARS-
CoV-2,” “Stomatognathic diseases,” “Oral manifestation,” 
and “Mouth disease” in PubMed, Scopus, and Science 
Direct databases among articles between 2010 and 
2020. Of 80 related articles, 42 were excluded due to 
lack of full text, being written in a language other than 
English or containing repetitive material and 38 were 
closely relevant to the title. Finding 24 well documented 
English articles were chosen, including clinical trial 
(5 articles), review (6 articles), cohort (2 articles), case 
report (3 articles), cross-sectional studies (1 article), and 
letter to editor (7 articles) were reviewed.
Results
Finally, we found four different types of oral 
manifestations of COVID-19 which are included 
as salivary gland disease, xerostomia, taste/smell 
alterations, and oral mucosal lesions (Table 1).
Discussion
There have been limited studies about oral 
manifestations of COVID-19, review of literature 
showed that most researchers paying more attention to 
systemic manifestations, and therefore we focused on 
oral-related symptoms, which may provide new clinical 
information for COVID-19.
In the following, we will refer to oral finding and 
its relation to clinical findings. Some of the side effects 
that we get after searching are:
Salivary Gland Disease
Salivary gland can be involved in patients with 
CoV infection [5]. Angiotensin-converting enzyme II 
(ACE2) has been reported as an important receptor 
for COVID-19 [6], [7]. Xu et al. demonstrated that the 
expression of ACE2 in minor salivary glands was higher 
than in lungs, which suggests salivary glands could be 
a potential target for COVID-19 [8]. In accordance to 
these findings, Chen et al. evaluated the expression of 
ACE2 receptor of 2019-nCoV in salivary gland epithelial 
cells and demonstrated the possibility of 2019-nCoV 
infection of the salivary glands. They also mentioned 
the reason that the positive saliva detection rate was 
as high as 75% in critically ill patients may be related to 
virus invasion caused by high viral loads or destroyed 
salivary glands at the late stage of the disease [9]. The 
same results have been also reported by To et al. and 
Kotfis and Skonieczna-Żydecka [10], [11]. It is important 
to know, COVID-19 was only detected in saliva, with no 
evidence for its presence in the nasopharynx [12].
Xerostomia
In a study by Chen et al., among the oral-
related symptoms in COVID-19 patients, amblygeustia 
(47.2%) overall, male (36.5%), female (57.1%) and 
xerostomia (46.3%) overall, male (46.2%), female 
(46.4%) had the most frequencies of occurrence. In 
addition, 11.1% male (13.5%) and female (8.90%) of 
the patients exhibited dryness and inflammation of the 
mouth. One female patient (0.9%) had enlargement 
of lymph nodes in the submandibular regions [8]. In a 
study by Yifan et al., the ten most frequent symptoms 
in the studied patients were chest discomfort (31.4%), 
dyspnea (30.7%), nausea (21.4%), headache (19.3%), 
dizziness (17.9%), xerostomia (15.7%), fatigue (15%), 
sleepiness (9.3%), sweating (8.6%), and waist pain 
(7.1%) [13]. Besides viral invasion to the salivary glands 
and its negative effect on peripheral and central nervous 
systems, dry mouth may also be due to the patient’s 
Table 1: Oral manifestations of COVID-19 in some published articles
Author Year of publication Oral manifestations
Salivary gland involvement Xerostomia Taste and Smell alterations Oral mucosal lesion
Xu et al. [7] 2020 *
Chen et al. [9] 2020 * * *
To et al. [10] 2020 *
Kotfis and Skonieczna-Żydecka [11] 2020 *
Keyhan et al. [12] 2020 *
Yifan et al. [13] 2020 *
Amorim Dos Santos et al. [1] 2020 * *
Odeh et al. [14] 2020 *
Giacomelli et al. [15] 2020 *
Lechien et al. [16] 2020 *
Vaira et al. [17] 2020 *
Hopkins et al. [18] 2020 *
Chaux-Bodard et al. [20] 2020 *
Martín Carreras-Presas et al. [22] 2020 *
Dziedzic and Wojtyczka [23] 2020 *
Vieira [24] *
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change in psychological status, poor oral hygiene, or 
adverse drug effects [9], [12]. According to Amorim Dos 
Santos et al., the occurrence of xerostomia in COVID-
19 patients linked to decreased salivary flow [1].
Taste and Smell Alterations
Taste and smell abnormalities have been 
recognized as symptoms of 2019-nCoV [14]. According to 
Giacomelli et al., about 34% of COVID-19 patients had at 
least one taste or olfactory disorders and 18.6% had both 
of them [15]. More than 20% of patients presented the 
symptoms before the hospital admission, whereas 13.5% 
experienced the symptoms during the hospitalization. 
Taste alterations were more common (91%) before 
hospitalization, whereas after hospitalization, taste and 
olfactory alteration appeared with an equal percentage. 
Women reported olfactory and taste disorders more 
frequently than men (52.6% vs. 25%). Moreover, patients 
with at least 1 olfactory and taste disorder were younger 
than those without [15]. In a multicenter European 
study by Lechien et al., 79.7% of patients with mild-
to-moderate forms of the coronavirus disease were 
hyposmic or anosmic [16]. In addition, according to Vaira 
et al., in 15.3% of patients, temporary taste and smell 
abnormalities were only manifestations of COVID-19 and 
there is a statistically significant relationship between the 
duration of the chemosensitive disorder and the severity 
of the disease [17]. For example, patients who had a 
history of taste and smell alteration for more than 10 days, 
the risk of developing a severe pulmonary clinical picture 
was 2.4 times greater [17]. In another study by Hopkins 
et al., 86.4% of patients reported complete anosmia 
and 11.5% reported a very severe loss of smell at the 
time of the first survey. At follow-up 1 week later, lower 
severity, unchanged severity, and higher severity scores 
have been reported in 80.1%, 17.6%, and 1.9% of cases, 
respectively [18]. These abnormalities could be explained 
by the interaction between virus and ACE2 receptors. In 
fact, the expression of ACE2 was found to be higher in 
the tongue, where the taste buds are most frequent than 
other sites such as gingival or buccal mucosa [9]. On the 
other hand, Keyhan et al. described that the presence of 
dysosmia and dysgeusia can be related to olfactory nerve 
and trigeminal nerve damage caused by virus invasion or 
excessive exposure to chemicals and disinfectant agents 
that are used by people due to the viral epidemic [12].
Oral Mucosal Lesions
Cutaneous lesions related to 2019-nCoV 
infection have been described by dermatologists [19], 
but to our knowledge, there is limited information 
about oral mucosal lesions with a proven COVID-19 
infection. In this regard, Chaux-Bodard et al. reported 
a COVID-19 related oral ulcer in a 45-year-old female. 
History of the lesion revealed painful inflammation 
on the dorsal side of the tongue, followed by 24 h of 
the erythematous macula, which changed into an 
asymptomatic and irregular ulcer. Three days after 
the occurrence of the oral lesion, asymptomatic 
erythematous area was appeared on the big toe; 
however, general symptoms were mild asthenia. The 
oral ulcer completely healed after 10 days without a 
scar. The tongue ulcer occurred after a short time of 
erythematous macular lesion, which could be explained 
by vasculitis [20]. COVID is in association with variable 
inflammatory reactions that can lead to vasculitis [21]. 
Thus, an irregular, acute, and solitary oral ulcer could 
be an inaugural symptom of 2019-nCoV infection which 
needs to be proven in large cohorts of patients [20]. In 
another case report by Martín Carreras-Presas et al., 
they showed oral vesiculobullous lesions associated 
with SARS-CoV-2 infection in three cases. The first 
case was a 56-year-old healthy male with the lesions 
resembled a herpetic recurrent stomatitis on the hard 
palate. The second case was a diabetic 58-year-
old male with multiple small ulcers on his palate with 
unilateral affection and the last case was a 65-year-old 
female with blisters in her internal lip mucosa as well as 
desquamative gingivitis. It is important to know that all 
reported cases had pain, oral ulcers, and blisters before 
seeking medical advice [22].
On the other hand, stomatitis, oral ulcers, and 
dry mouth may be related to the side effects of anti-
viral drugs such as interferon-alpha and beta in <2% of 
cases [23].
Amorim Dos Santos et al., in a case report 
study, showed that COVID-19 could potentially 
contribute to adverse outcomes concerning oral health, 
likely leading to various opportunistic fungal infections, 
recurrent oral herpes simplex virus-1 infection, and 
gingivitis as a result of the impaired immune system 
and/or due to treatments for COVID-19 [1]. Vieira 
showed that in severe cases of COVID-19, prior 
underlying untreated moderate or severe periodontitis 
may worsen COVID-19. Hence, periodontal therapy in 
patient with initial symptoms of COVID-19 may reduce 
the risk of the condition to become severe [24].
Conclusion
Salivary gland disease, xerostomia, taste and 
smell alternation and oral mucosal lesions are the 
most common oral changes reported about COVID-
19. Since almost all of the oral findings appear at 
asymptomatic phase of disease, identification of these 
 Mortazavi et al. Oral manifestations of COVID-19
Open Access Maced J Med Sci. 2020 Sep 25; 8(T1):286-289. 289
symptoms can help to timely diagnosis of the main 
disease. Furthermore, it is unclear that these oral 
manifestations are coexisting or the result of a cause 
and effect that the virus reality has the ability to cause 
these manifestations. Due to the fact that the virus has 
not been around for a long time and many of the long-
term effects of the virus have not been known yet, more 
extensive studies are needed.
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